Aardvark Therapeutics, Inc. AARD
5.06
(0.49)
(8.83%)
as of 25 Sep
- Market cap
- $121.5M
- P/E
- 0.0×
Follow AARD
Insider Buys
alert about insiders buying in the last 12 month
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | |
|---|---|---|---|---|
Current Ratio |
10.61 | 15.05 | 7.50 | 27.72 |
Net Debt/EBITDA |
1.72 | 3.22 | 1.35 | 1.43 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
0.94 | 0.88 | 0.81 | 0.78 |
Capex/Depreciation |
0.07 | 1.36 | — | 0.00 |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 |
| (221.55%) | 46.03% | 22.98% | 0.00% | |
| (59.16%) | (46.77%) | (52.82%) | 0.00% | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(56.83%) | (29.75%) | (80.21%) | (85.33%) |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(2.77) | (4.55) | (1.47) | (2.71) |
Cash per Share |
5.61 | 18.43 | 2.52 | 4.14 |
Shareholders Equity per Share |
5.43 | 18.04 | 2.30 | 4.11 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
5.43 | 18.04 | 2.30 | 4.11 |
Free Cash Flow |
(54.27) | (18.20) | (5.82) | (10.54) |
Working Capital |
101.34 | 69.21 | 8.99 | 15.90 |
Capital Expenditures |
(0.09) | (0.11) | — | — |
Net Current Asset Value |
101.34 | 68.74 | 8.93 | 15.72 |
| Other line items | ||||
Quick Ratio |
10.43 | 14.95 | 7.23 | 27.07 |
Depreciation/Fixed assets |
0.00 | 0.00 | — | 0.00 |
Cash ROIC |
(25.00%) | (12.41%) | (30.51%) | (32.86%) |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(2.76) | (4.53) | (1.47) | (2.71) |
Capex per Share |
0.00 | (0.03) | 0.00 | 0.00 |
Average Payables |
2.19 | 1.67 | 0.65 | — |
Average Assets |
97.34 | 44.02 | 13.65 | — |
Average Common Equity |
26.00 | (44.72) | (31.36) | — |
Capex to Sales |
0.00 | 0.00 | — | — |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates